drugset / Trial / NCT04092621

Rapid Atrial Fibrillation Treatment Strategy

NCT04092621

Phase 4 Unknown 40 enrolled Our Lady of the Lake Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Prospective, randomized, open-label clinical trial studying the treatment of new onset atrial fibrillation in critically ill patients with septic shock. Patients will be assigned to rhythm vs rate control strategies with various outcome measures assessed.

Timeline

Start
2019-09-16
Primary completion
2020-09-15
Completion
2020-09-15

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Amiodarone Small molecule 200 mg Intravenous
Comparator Digoxin Other / unclassified